Posted in NEWS Roche to stop studies of gantenerumab in early Alzheimer’s after trials fail December 1, 2022 Roche (RHHBY) (RHHBF) said it would stop studies of itsĀ medicine gantenerumab in early Alzheimer’s disease after the drug did not meet the main goal of slowing clinical decline … https://seekingalpha.com/news/3913125-roche-to-stop-studies-of-gantenerumab-in-early-alzheimers-after-trials-fail